A Frailty Scale Predicts Outcomes of Patients with Newly Diagnosed Multiple Myeloma Who Are Ineligible for Transplant Treated with Continuous Lenalidomide Plus Low-Dose Dexamethasone on the First Trial

被引：12

作者：

Facon, Thierry ^{[1
]}

Hulin, Cyrille ^{[2
]}

Dimopoulos, Meletios A. ^{[3
]}

Belch, Andrew ^{[4
]}

Meuleman, Nathalie ^{[5
]}

Mohty, Mohamad ^{[6
]}

Chen, Wen-Ming ^{[7
]}

Kim, Kihyun ^{[8
]}

Zamagni, Elena ^{[9
]}

Rodriguez-Otero, Paula ^{[10
]}

Renwick, William ^{[11
]}

Rose, Christian ^{[12
]}

Tempescul, Adrian ^{[13
]}

Palumbo, Antonio ^{[14
]}

Guo, Shien ^{[15
]}

Sturniolo, Michael ^{[16
]}

Ervin-Haynes, Annette ^{[16
]}

Fermand, Jean-Paul ^{[17
]}

机构：

[1] CHRU Lille, Hop Claude Huriez, Malad Sang, F-59037 Lille, France

[2] CHU BORDEAUX, Bordeaux, France

[3] Univ Athens, Sch Med, Athens 11528, Greece

[4] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada

[5] Univ Libre Bruxelles, Jules Bordet Insitute, Dept Hematol, Brussels, Belgium

[6] St Antoine Hosp, Dept Haematol, Paris, France

[7] Beijing Chaoyang Hosp, Beijing, Peoples R China

[8] Sungkyunkwan Univ, Samsung Med Ctr, Seoul, South Korea

[9] Azienda Osped Univ, Bologna, Italy

[10] Univ Navarra Clin, Pamplona, Spain

[11] Western Hlth, St Albans, Australia

[12] Hop St Vincent, Dept Hematol, Lille, France

[13] CHU Brest, Dept Hematol, F-29285 Brest, France

[14] Univ Turin, Turin, Italy

[15] Evidera, Boston, MA USA

[16] Celgene Corp, Summit, NJ USA

[17] Hop St Louis, AP HP, Serv Immunohematol, Paris, France

来源：

BLOOD | 2015年 / 126卷 / 23期

关键词：

D O I：

10.1182/blood.V126.23.4239.4239

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[1] A FRAILTY SCALE PREDICTS OUTCOMES IN TRANSPLANT-INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH CONTINUOUS LENALIDOMIDE PLUS LOW-DOSE DEXAMETHASONE IN THE FIRST (MM-020) TRIAL
Facon, T.
Hulin, C.
Dimopoulos, M. A.
Belch, A.
Meuleman, N.
Mohty, M.
Chen, W. M.
Kim, K.
Zamagni, E.
Rodriguez-Otero, P.
Renwick, W.
Rose, C.
Tempescul, A.
Boyle, E.
Palumbo, A.
Guo, S.
Monzini, M. S.
Sturniolo, M.
Ervin-Haynes, A.
Fermand, J. P.
HAEMATOLOGICA, 2016, 101 : 258 - 259
[2] Impact of Cytogenetics on Outcomes of Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma Treated with Continuous Lenalidomide Plus Low-Dose Dexamethasone in the First (MM-020) Trial
Avet-Loiseau, Herve
Hulin, Cyrille
Benboubker, Lofti
Dimopoulos, Meletios A.
Belch, Andrew
Reece, Donna
Catalano, John
Pinto, Antonio
Ludwig, Heinz
Bahlis, Nizar J.
Cavo, Michele
Attal, Michel
Moreau, Philippe
Qiu, Lugui
LeBlanc, Richard
Schots, Rik
Rajkumar, S. Vincent
Marek, Jennifer
Chen, Guang
Yiu, Wai
Ervin-Haynes, Annette
Facon, Thierry
BLOOD, 2015, 126 (23)
[3] THE FIRST TRIAL: ANALYSIS OF THE ASIAN SUBGROUP OF TRANSPLANT-INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH CONTINUOUS LENALIDOMIDE AND LOW-DOSE DEXAMETHASONE
Lu, J.
Lee, J. H.
Huang, S. Y.
Qiu, L.
Lee, J. J.
Liu, T.
Yoon, S. S.
Kim, K.
Shen, Z. X.
Eom, H. S.
Chen, W. M.
Min, C. K.
Kim, H. J.
Lee, J. O.
Kwak, J. Y.
Yiu, W.
Chen, G.
Ervin-Haynes, A.
Hulin, C.
Facon, T.
HAEMATOLOGICA, 2016, 101 : 548 - 549
[4] Continuous Treatment with Lenalidomide and Low-Dose Dexamethasone in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma in Asia: Subanalysis of the First Trial
Lu, Jin
Lee, Jae Hoon
Huang, Shang-Yi
Qiu, Lugui
Lee, Je-Jung
Liu, Ting
Yoon, Sung-Soo
Kim, Kihyun
Shen, Zhi Xiang
Eom, HyeonSeok
Chen, Wenming
Min, Chang-Ki
Kim, Hyo Jung
Lee, Jeong Ok
Kwak, Jae Yong
Yiu, Wai
Chen, Guang
Haynes, Annette Ervin
Hulin, Cyrille
Facon, Thierry
BLOOD, 2015, 126 (23)
[5] Continuous treatment with lenalidomide and low-dose dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma in Asia: subanalysis of the FIRST trial
Lu, Jin
Lee, Jae H.
Huang, Shang-Yi
Qiu, Lugui
Lee, Je-Jung
Liu, Ting
Yoon, Sung-Soo
Kim, Kihyun
Shen, Zhi X.
Eom, Hyeon S.
Chen, Wen M.
Min, Chang K.
Kim, Hyo J.
Lee, Jeong O.
Kwak, Jae Y.
Yiu, Wai
Chen, Guang
Ervin-Haynes, Annette
Hulin, Cyrille
Facon, Thierry
BRITISH JOURNAL OF HAEMATOLOGY, 2017, 176 (05) : 743 - 749
[6] A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trial
Facon, Thierry
Dimopoulos, Meletios A.
Meuleman, Nathalie
Belch, Andrew
Mohty, Mohamad
Chen, Wen-Ming
Kim, Kihyun
Zamagni, Elena
Rodriguez-Otero, Paula
Renwick, William
Rose, Christian
Tempescul, Adrian
Boyle, Eileen
Manier, Salomon
Attal, Michel
Moreau, Philippe
Macro, Margaret
Leleu, Xavier
Chretien, Marie Lorraine
Ludwig, Heinz
Guo, Shien
Sturniolo, Michael
Tinel, Antoine
Monzini, Mara Silvia
Costa, Bruno
Houck, Vanessa
Hulin, Cyrille
Mary, Jean Yves
LEUKEMIA, 2020, 34 (01) : 224 - 233
[7] A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trial
Thierry Facon
Meletios A. Dimopoulos
Nathalie Meuleman
Andrew Belch
Mohamad Mohty
Wen-Ming Chen
Kihyun Kim
Elena Zamagni
Paula Rodriguez-Otero
William Renwick
Christian Rose
Adrian Tempescul
Eileen Boyle
Salomon Manier
Michel Attal
Philippe Moreau
Margaret Macro
Xavier Leleu
Marie Lorraine Chretien
Heinz Ludwig
Shien Guo
Michael Sturniolo
Antoine Tinel
Mara Silvia Monzini
Bruno Costa
Vanessa Houck
Cyrille Hulin
Jean Yves Mary
Leukemia, 2020, 34 : 224 - 233
[8] Continuous lenalidomide and low-dose dexamethasone in patients with transplant-ineligible newly diagnosed MM: FIRST trial subanalysis of Canadian/US patients
Belch, Andrew
Bahlis, Nizar
White, Darrell
Cheung, Matthew
Chen, Christine
Shustik, Chaim
Song, Kevin
Tosikyan, Axel
Dispenzieri, Angela
Anderson, Kenneth
Brown, Diane
Robinson, Suzanne
Srinivasan, Shankar
Facon, Thierry
CANCER MEDICINE, 2020, 9 (23): : 8923 - 8930
[9] Daratumumab plus lenalidomide and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: frailty subgroup analysis of MAIA
Facon, Thierry
Cook, Gordon
Usmani, Saad Z.
Hulin, Cyrille
Kumar, Shaji
Plesner, Torben
Touzeau, Cyrille
Bahlis, Nizar J.
Basu, Supratik
Nahi, Hareth
Goldschmidt, Hartmut
Quach, Hang
Mohty, Mohamad
Venner, Christopher P.
Weisel, Katja
Raje, Noopur
Hebraud, Benjamin
Belhadj-Merzoug, Karim
Benboubker, Lotfi
Decaux, Olivier
Manier, Salomon
Caillot, Denis
Ukropec, Jon
Pei, Huiling
Van Rampelbergh, Rian
Uhlar, Clarissa M.
Kobos, Rachel
Zweegman, Sonja
LEUKEMIA, 2022, 36 (04) : 1066 - 1077
[10] Daratumumab plus lenalidomide and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: frailty subgroup analysis of MAIA
Thierry Facon
Gordon Cook
Saad Z. Usmani
Cyrille Hulin
Shaji Kumar
Torben Plesner
Cyrille Touzeau
Nizar J. Bahlis
Supratik Basu
Hareth Nahi
Hartmut Goldschmidt
Hang Quach
Mohamad Mohty
Christopher P. Venner
Katja Weisel
Noopur Raje
Benjamin Hebraud
Karim Belhadj-Merzoug
Lotfi Benboubker
Olivier Decaux
Salomon Manier
Denis Caillot
Jon Ukropec
Huiling Pei
Rian Van Rampelbergh
Clarissa M. Uhlar
Rachel Kobos
Sonja Zweegman
Leukemia, 2022, 36 : 1066 - 1077

← 1 2 3 4 5 →